These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33386219)

  • 21. [Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
    Jiang H; Guan RJ; Wang HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):239-44. PubMed ID: 23879951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL; Guan RJ; Li JJ
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats.
    Ichimura K; Matoba T; Koga JI; Nakano K; Funamoto D; Tsutsui H; Egashira K
    Int Heart J; 2018 Nov; 59(6):1432-1444. PubMed ID: 30369578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticle-mediated delivery of nuclear factor kappaB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension.
    Kimura S; Egashira K; Chen L; Nakano K; Iwata E; Miyagawa M; Tsujimoto H; Hara K; Morishita R; Sueishi K; Tominaga R; Sunagawa K
    Hypertension; 2009 May; 53(5):877-83. PubMed ID: 19307469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor Necrosis Factor-α-Induced Protein-8-like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole-Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells.
    Li J; He X; Liu F; Zheng X; Jiang J
    J Cardiovasc Pharmacol; 2024 Jan; 83(1):73-85. PubMed ID: 38180455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethyl Pyruvate Alleviates Pulmonary Hypertension through the Suppression of Pulmonary Artery Smooth Muscle Cell Proliferation via the High Mobility Group Protein B1/Receptor for Advanced Glycation End-Products Axis.
    Liu C; Sun H; Tang M; Li J; Zhang X; Cao G
    Ann Thorac Cardiovasc Surg; 2021 Dec; 27(6):380-388. PubMed ID: 34011805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
    Chang H; Chang CY; Lee HJ; Chou CY; Chou TC
    Phytomedicine; 2018 Dec; 51():205-213. PubMed ID: 30466619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inositol monophosphatase 1 as a novel interacting partner of RAGE in pulmonary hypertension.
    Rafikov R; McBride ML; Zemskova M; Kurdyukov S; McClain N; Niihori M; Langlais PR; Rafikova O
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L428-L444. PubMed ID: 30604625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blueberry extract decreases oxidative stress and improves functional parameters in lungs from rats with pulmonary arterial hypertension.
    Türck P; Fraga S; Salvador I; Campos-Carraro C; Lacerda D; Bahr A; Ortiz V; Hickmann A; Koetz M; Belló-Klein A; Henriques A; Agostini F; da Rosa Araujo AS
    Nutrition; 2020 Feb; 70():110579. PubMed ID: 31743815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.
    Zhu R; Bi L; Kong H; Xie W; Hong Y; Wang H
    Int J Clin Exp Pathol; 2015; 8(10):12169-76. PubMed ID: 26722401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline.
    Thomas M; Docx C; Holmes AM; Beach S; Duggan N; England K; Leblanc C; Lebret C; Schindler F; Raza F; Walker C; Crosby A; Davies RJ; Morrell NW; Budd DC
    Am J Pathol; 2009 Feb; 174(2):380-9. PubMed ID: 19116361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
    Molecules; 2018 May; 23(6):. PubMed ID: 29861433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.
    Wang Y; Tian W; Xiu C; Yan M; Wang S; Mei Y
    Clin Rheumatol; 2019 Jan; 38(1):29-35. PubMed ID: 29362961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL; Guan RJ; Xu QH; Wu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
    Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral adipose tissue-derived serine protease inhibitor prevents the development of monocrotaline-induced pulmonary arterial hypertension in rats.
    Sakamoto Y; Kameshima S; Kakuda C; Okamura Y; Kodama T; Okada M; Yamawaki H
    Pflugers Arch; 2017 Nov; 469(11):1425-1432. PubMed ID: 28776262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.
    Liu HM; Jia Y; Zhang YX; Yan J; Liao N; Li XH; Tang Y
    Acta Pharmacol Sin; 2019 Apr; 40(4):477-485. PubMed ID: 30038339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
    Ding M; Lei J; Qu Y; Zhang H; Xin W; Ma F; Liu S; Li Z; Jin F; Fu E
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):562-70. PubMed ID: 25636073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.